RDNT vs. DGX

In the year-to-date period, RDNT achieves a -28.04% return, which is significantly lower than DGX's 16.31% return. Over the past 10 years, RDNT has outperformed DGX with an annualized return of 18.88%, while DGX has yielded a comparatively lower 11.26% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for RadNet, Inc. (RDNT) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RDNT Sharpe Ratio is 0.06, which is lower than the DGX Sharpe Ratio of 1.33. The chart below compares the historical Sharpe Ratios of RDNT and DGX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

RDNT has not paid dividends to shareholders, while DGX's dividend yield for the trailing twelve months is around 1.76%.

The maximum RDNT drawdown since its inception was -92.15%, which is greater than DGX's maximum drawdown of -49.46%. Use the drawdown chart below to compare losses from any high point for RDNT and DGX. For additional features, visit the drawdowns tool.

RadNet, Inc. (RDNT) has a higher volatility of 16.65% compared to Quest Diagnostics Incorporated (DGX) at 9.76%. This indicates that RDNT's price experiences larger fluctuations and is considered to be riskier than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between RadNet, Inc. and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.